Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-05

Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Celiac Disease

View source ↗

Summary

A pilot study on the role of gut flora in celiac disease has been withdrawn from clinical trial participation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProgenaBiome gut flora intervention

Snippet

Sponsor: ProgenaBiome | Conditions: Celiac Disease | Status: WITHDRAWN